Bio-Rad Laboratories (BIO) EBITDA Margin (2009 - 2017)
Bio-Rad Laboratories (BIO) posted EBITDA Margin of 13.88% for Q3 2017, up 1.85 percentage points from 12.03% a year earlier and up 6.88 percentage points from the prior quarter.
Powered by 
Analysis
Bio-Rad Laboratories (BIO) EBITDA Margin (2009 - 2017) Analysis & Trends
For the trailing twelve months through Sep 30, 2017, EBITDA Margin at Bio-Rad Laboratories was 10.92%, down 0.99 percentage points year-over-year.
- The Q3 2017 figure stands as the highest quarterly EBITDA Margin since Q3 2015.
- On a year-over-year basis, EBITDA Margin increased in two of the last six quarters, with an average year-over-year change of -1.60 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q1 2015, with a gain of 2.87 percentage points; the weakest was Q3 2013, with a drop of 6.57 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 31.93% |
| 10 | Bio-Rad Laboratories | 10.10 Bn | 3.96 Bn | 345.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 13.88% |
| Jun 30, 2017 | 7.00% |
| Mar 31, 2017 | 11.97% |
| Sep 30, 2016 | 12.03% |
| Jun 30, 2016 | 12.48% |
| Mar 31, 2016 | 11.52% |
| Sep 30, 2015 | 14.09% |
| Jun 30, 2015 | 14.29% |
| Mar 31, 2015 | 14.09% |
| Sep 30, 2014 | 13.26% |
| Jun 30, 2014 | 15.28% |
| Mar 31, 2014 | 11.22% |
| Sep 30, 2013 | 13.07% |
| Jun 30, 2013 | 16.72% |
| Mar 31, 2013 | 13.70% |
| Sep 30, 2012 | 19.65% |
| Jun 30, 2012 | 20.56% |
| Mar 31, 2012 | 17.57% |
| Sep 30, 2011 | 20.19% |
| Jun 30, 2011 | 18.75% |
API Access
Bio-Rad Laboratories EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();